Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice

Journal of Pineal Research

Volumn 47, Issue 4, 2009, Pages 324-329

  Kim, Tae Ho ^a   Jung, Jung A ^a   Kim, Gun Dong ^a   Jang, An Hee ^a   Ahn, Hyun Jong ^a   Park, Yong Seek ^a   Park, Cheung Seog ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

2,4 dinitrofluorobenzene; Atopic dermatitis; CD4+ T cells; Melatonin; NC Nga

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG INHIBITION; EAR; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPH NODE; MOUSE; MOUSE STRAIN; NC NGA MOUSE; NONHUMAN; PINEAL BODY; REPRODUCTION; SKIN DEFECT;

ANIMALS; ANTIOXIDANTS; DERMATITIS, ATOPIC; DINITROFLUOROBENZENE; MALE; MELATONIN; MICE; SKIN DISEASES;

EID: 70350074606     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00718.x     Document Type: Article

References (48)

1. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000 105 : 860 876.
2. Munoz-Hoyos A, Espin-Quirantes C, Molina-Carballo A et al. Neuroendocrine and circadian aspects (melatonin and beta-endorphin) of atopic dermatitis in the child. Pediatr Allergy Immunol 2007 18 : 679 686.
3. Kelsay K. Management of sleep disturbance associated with atopic dermatitis. J Allergy Clin Immunol 2006 118 : 198 201.
4. Miyauchi-Hashimoto H, Okamoto H, Sugihara A et al. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice. Photodermatol Photoimmunol Photomed 2005 21 : 125 130.
5. Jin H, He R, Oyoshi M et al. Animal models of atopic dermatitis. J Invest Dermatol 2009 129 : 31 40.
6. Lee SJ, Oh SG, Seo SW et al. Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice. Biol Pharm Bull 2007 30 : 1468 1471.
7. Dearman RJ, Basketter DA, Kimber I. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol Appl Pharmacol 1996 138 : 308 316. (Pubitemid 26227602)
8. Shiohara T, Hayakawa J, Mizukawa Y. Animal models for atopic dermatitis: are they relevant to human disease? J Dermatol Sci 2004 36 : 1 9.
9. Tomimori Y, Tanaka Y, Goto M et al. Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition. J Invest Dermatol 2005 124 : 119 124.
10. Kim DY, Jung JA, Kim TH et al. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice. J Ethnopharmacol 2009 122 : 567 572.
11. Reiter RJ. The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980 1 : 109 131.
12. Bob P, Fedor-Freybergh P. Melatonin, consciousness, and traumatic stress. J Pineal Res 2008 44 : 341 347.
13. Fischer TW, Slominski A, Tobin DJ et al. Melatonin and the hair follicle. J Pineal Res 2008 44 : 1 15.
14. Koppisetti S, Jenigiri B, Terron MP et al. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci 2008 53 : 2592 2603.
15. Slominski A, Pisarchik A, Semak I et al. Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur J Biochem 2003 270 : 3335 3344.
16. Slominski A, Pisarchik A, Semak I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002 16 : 896 898.
17. Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/ melatoninergic system: securing a place under the sun. FASEB J 2005 19 : 176 194.
18. Fischer TW, Sweatman TW, Semak I et al. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 2006 20 : 1564 1566.
19. Slominski A, Baker J, Rosano TG et al. Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem 1996 271 : 12281 12286.
20. Slominski A, Tobin DJ, Zmijewski MA et al. Melatonin in the skin: synthesis, metabolism and functions. Trends Endo Metab 2008 19 : 17 24.
21. Jaworek J, Nawrot-Porabka K, Leja-Szpak A et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007 58 (Suppl. 6 65 80.
22. Santello FH, Frare EO, Dos Santos CD et al. Melatonin treatment reduces the severity of experimental Trypanosoma cruzi infection. J Pineal Res 2007 42 : 359 363.
23. Esposito E, Iacono A, Muia C et al. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 2008 44 : 78 87.
24. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
25. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
26. Huang SH, Cao XJ, Wei W. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. J Pineal Res 2008 45 : 93 100.
27. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
28. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
29. Hardeland R, Backhaus C, Fadavi A. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 2007 43 : 382 388.
30. Majewska M, Zajac K, Zemelka M et al. Influence of melatonin and its precursor L-tryptophan on Th1 dependent contact hypersensitivity. J Physiol Pharmacol 2007 58 (Suppl. 6 125 132.
31. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997 9 : 461 466.
32. Shimizu N, Dairiki K, Ogawa S et al. Dietary whey protein hydrolysate suppresses development of atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. Allergol Int 2006 55 : 185 189.
33. Kawakami Y, Yumoto K, Kawakami T. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergol Int 2007 56 : 403 409.
34. Hashimoto Y, Arai I, Nakanishi Y et al. Scratching of their skin by NC/Nga mice leads to development of dermatitis. Life Sci 2004 76 : 783 794. (Pubitemid 39576152)
35. Angeli V, Staumont D, Charbonnier AS et al. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 2004 172 : 3822 3829.
36. Jan JE, Reiter RJ, Wasdell MB et al. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009 46 : 1 7.
37. Ryoo YW, Suh SI, Mun KC et al. The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J Dermatol Sci 2001 27 : 162 169.
38. Dreher F, Denig N, Gabard B et al. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology 1999 198 : 52 55.
39. Tanaka M, Aiba S, Matsumura N et al. IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis. Arch Dermatol 1994 130 : 1393 1401.
40. Lee CH, Chuang HY, Shih CC et al. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006 154 : 1100 1107.
41. Uehara M. Heterogeneity of serum IgE levels in atopic dermatitis. Acta Derm Venereol 1986 66 : 404 408.
42. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996 383 : 787 793.
43. Frostegard J, Ulfgren AK, Nyberg P et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 145 : 33 43.
44. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994 12 : 227 257.
45. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997 18 : 263 266.
46. Moller DR, Forman JD, Liu MC et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996 156 : 4952 4960.
47. Shaji AV, Kulkarni SK, Agrewala JN. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells. Clin Exp Immunol 1998 111 : 181 185.
48. + cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997 159 : 574 581.